Abstract:Petro Virych, 1 Pavlo Virych, 2 Volodymyr Prokopiuk, 3, 4 Anatolii Onishchenko, 3 Mykola Ischenko, 2 Volodymyr Doroschuk, 2 Valentyna Kurovska, 5 Anton Tkachenko, 4 Nataliya Kutsevol 2 1 Laboratory of Mechanisms of Drug Resistance, R.E. Kavetsky Institute for Experimental Pathology, Oncology and Radiobiology, Kyiv, Ukraine; 2 Faculty of Chemistry, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; 3 Research Institute of Experimental and Clinical Medicine, Kharkiv National Medical University, Kharkiv, Ukraine; 4 Department of Cryobiochemistry, Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine; 5 Educational and Scientific Center "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Kyiv, Ukraine Correspondence: Pavlo Virych, Faculty of Chemistry, Taras Shevchenko National University of Kyiv, 60 Volodymyrska str, Kyiv, 01601, Ukraine, Email Anton Tkachenko, Department of Cryobiochemistry, Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, 23 Pereyaslavskaya St, Kharkiv, 61015, Ukraine, Email Introduction: Tumor drug resistance and systemic toxicity are major challenges of modern anticancer therapy. Nanotechnology makes it possible to create new materials with the required properties for anticancer therapy. Methods: In this research, Dextran-graft-Polyacrylamide/ZnO nanoparticles were used. The study was carried out using prostate (DU-145, LNCaP, PC-3), breast (MDA-MB-231, MCF-7, MCF-7 Dox) cancer cells and non-malignant (MAEC, BALB/3T3 clone A31) cells. Zinc was visualized with fluorescence in vitro and in vivo. ROS and apoptotic markers were identified by cytometry. Zinc accumulation and histopathological changes in the tumor, liver, kidney, and spleen were evaluated in a rat model. Results: ZnO nanoparticles dissociation and release of Zn 2+ into the cytosol occurs in 2– 3 hours for cancerous and non-cancerous cells. ROS upregulation was detected in all cells. For non-malignant cells, the difference between the initial ROS level was insignificant. The rate of carbohydrate metabolism in cancer cells was reduced by nanosystems. Zinc level in the tumor was upregulated by 25% and 39% after treatment with nanosystems and doxorubicin combined, respectively. The tumor Walker-256 carcinosarcoma volume was reduced twice following mono-treatment with the nanocomplex and 65-fold lower when the nanocomplex was combined with doxorubicin compared with controls. In the liver, kidney and spleen, the zinc level increased by 10– 15% but no significant pathological alterations in the tissues were detected. Conclusion: D-PAA/ZnO NPs nanosystems were internalized by prostate, breast cancer cells and non-malignant cells via endocytosis after short time, but cytotoxicity against non-cancer cells were significantly lower in vitro and in vivo. D-PAA/ZnO NPs nanocomplex efficiently promoted cell death of tumor cells without showing cytotoxicity against non-malignant cells making it a promising anti-cancer agent. Keywords: zinc oxide nanoparticles, doxorubicin, prostate cancer, breast cancer, zinc imaging, histopathology The last few decades have witnessed significant advances in nanotechnology. The organization of materials into nanoscale structures noticeably changes their properties. Nanosize-mediated characteristics allow nanoparticles to interact with cellular structures in a special way. 1 All nanomaterials have a large surface area-to- volume ratio, which significantly increases their reaction properties. Despite significant progress in nanomedicine, our knowledge of intricate mechanisms that govern interactions between nanomaterials, cells and tissues are still ambiguous. 2 Zinc oxide nanoparticles (ZnO NPs) have semiconductor properties, which allow them to be applied in electronics, optics, photocatalysis, cosmetics, and medicine. 3 There is abundant evidence that zinc is low-toxic to cells at physiological conditions (pH = 7.4). 4 ZnO NPs have a high biocompatibility due to weak dissociation and Zn 2+ release. Nevertheless, it has been reported that ZnO NPs cause oxidative stress and cell damage at slightly acidic pH. Tumor cells stimulate significant changes in environmental tissues. Tumor microenvironment (TME) of various cancer types is different, but hallmark features include blood vessels, immune cells and extracellular matrix. The TME dynamically changes in response to hypoxia and decreased pH. The Warburg effect promotes the production of lactate and its efflux in -Abstract Truncated-

Zinc-Doped Iron Oxide Nanoparticles as a Proton-Activatable Agent for Dose Range Verification in Proton Therapy

[The preliminary report of a registration clinical trial of proton and heavy ion irradiation].

Iodine substituted hydroxyapatite nanoparticles and activation of derived ceramics for range verification in proton therapy

The Photodynamic Effect of Different Size ZnO Nanoparticles on Cancer Cell Proliferation in Vitro

Synergetic enhancing effects between platinum nano-sensitizers and clinically approved stabilizing ligands in proton therapy, causing high-yield double-strand breaks of plasmid DNA at relevant dose

Enhancing Proton Therapy Efficacy Through Nanoparticle-Mediated Radiosensitization

Antitumor Activity of the Zinc Oxide Nanoparticles Coated with Low-Molecular-Weight Heparin and Doxorubicin Complex<i> In</i><i> Vitro</i> and In Vivo

In vivo production of fluorine-18 in a chicken egg tumor model of breast cancer for proton therapy range verification

Phase-change ultrasound contrast agents for proton range verification: towards an in vivo application

Dextran-Graft-Polyacrylamide/Zinc Oxide Nanoparticles Inhibit of Cancer Cells in vitro and in vivo

Boron Nanoparticle-Enhanced Proton Therapy: Molecular Mechanisms of Tumor Cell Sensitization

Smart Design of ZnFe and ZnFe@Fe Nanoparticles for MRI‐tracked Magnetic Hyperthermia Therapy: Challenging Classical Theories of Nanoparticles Growth and Nanomagnetism

Transition metal doped hydrophilic ultrasmall iron oxide modulate MRI contrast performance for accurate diagnosis of orthotopic prostate cancer

Synthesis, chemical and biochemical characterization of Lu2O3-iPSMA nanoparticles activated by neutron irradiation

Reaction yields and angular distributions of prompt γ -rays for range verification in proton therapy using 18O

Zinc oxide nanoparticles modulate the gene expression of ZnT1 and ZIP8 to manipulate zinc homeostasis and stress-induced cytotoxicity in human neuroblastoma SH-SY5Y cells

In Situ Detection of the Zn(2+) Release Process of ZnO NPs in Tumour Cells by Confocal Laser Scanning Fluorescence Microscopy.

TiO2-ZnPc nanoparticles functionalized with folic acid as a target photosensitizer for photodynamic therapy against glioblastoma cells

Synthesis of Gd-DTPA Carborane-Containing Compound and Its Immobilization on Iron Oxide Nanoparticles for Potential Application in Neutron Capture Therapy

pH-responsive Photinia glabra-zinc oxide-protoporphyrin IX nanoconjugates with enhanced cellular uptake for photodynamic therapy towards cancer cells

Molecular MR Imaging of Prostate Cancer by Specified Iron Oxide Nanoparticles With PSMA-11 Peptides: A Preclinical Study